{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T02:02:45Z","timestamp":1787796165152,"version":"build-2784847793"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2024,1,3]],"date-time":"2024-01-03T00:00:00Z","timestamp":1704240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,1,3]],"date-time":"2024-01-03T00:00:00Z","timestamp":1704240000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Res Cardiol"],"published-print":{"date-parts":[[2024,7]]},"DOI":"10.1007\/s00392-023-02351-9","type":"journal-article","created":{"date-parts":[[2024,1,3]],"date-time":"2024-01-03T14:02:43Z","timestamp":1704290563000},"page":"1017-1029","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Safety and efficacy of everolimus-eluting bioresorbable vascular scaffold for cardiac allograft vasculopathy (CART)"],"prefix":"10.1007","volume":"113","author":[{"given":"Michele","family":"Pighi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabrizio","family":"Tomai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simone","family":"Fezzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2770-8231","authenticated-orcid":false,"given":"Gabriele","family":"Pesarini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Petrolini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonardo","family":"Spedicato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Tarantini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Ferlini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Calabr\u00f2","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno","family":"Loi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valeria","family":"Ferrero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Natalia Tovar","family":"Forero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joost","family":"Daemen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Flavio","family":"Ribichini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,1,3]]},"reference":[{"key":"2351_CR1","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1016\/j.healun.2010.05.017","volume":"29","author":"MR Mehra","year":"2010","unstructured":"Mehra MR, Crespo-Leiro MG, Dipchand A et al (2010) International society for heart and lung transplantation working formulation of a standardized nomenclature for cardiac allograft vasculopathy-2010. J Hear Lung Transplant 29:717\u2013727. https:\/\/doi.org\/10.1016\/j.healun.2010.05.017","journal-title":"J Hear Lung Transplant"},{"key":"2351_CR2","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1016\/j.jchf.2017.09.014","volume":"5","author":"M Tremblay-Gravel","year":"2017","unstructured":"Tremblay-Gravel M, Racine N, De Denus S et al (2017) Changes in outcomes of cardiac allograft vasculopathy over 30 years following heart transplantation. JACC Hear Fail 5:891\u2013901","journal-title":"JACC Hear Fail"},{"key":"2351_CR3","doi-asserted-by":"publisher","DOI":"10.1016\/j.trre.2020.100569","author":"M Pighi","year":"2020","unstructured":"Pighi M, Gratta A, Marin F et al (2020) Cardiac allograft vasculopathy: pathogenesis, diagnosis and therapy. Transplant Rev. https:\/\/doi.org\/10.1016\/j.trre.2020.100569","journal-title":"Transplant Rev"},{"key":"2351_CR4","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.jacc.2016.04.033","volume":"68","author":"S Chih","year":"2016","unstructured":"Chih S, Chong AY, Mielniczuk LM et al (2016) Allograft vasculopathy the achilles\u2019 heel of heart transplantation. J Am Coll Cardiol 68:80\u201391","journal-title":"J Am Coll Cardiol"},{"key":"2351_CR5","doi-asserted-by":"publisher","first-page":"2174","DOI":"10.1016\/j.jcin.2022.07.015","volume":"15","author":"R Scarsini","year":"2022","unstructured":"Scarsini R, Fezzi S, Leone AM et al (2022) Functional patterns of coronary disease diffuse, focal, and serial lesions. JACC Cardiovasc Interv 15:2174\u20132191. https:\/\/doi.org\/10.1016\/j.jcin.2022.07.015","journal-title":"JACC Cardiovasc Interv"},{"key":"2351_CR6","doi-asserted-by":"publisher","DOI":"10.4244\/AIJ-D-22-00022","author":"S Fezzi","year":"2022","unstructured":"Fezzi S, Huang J, Lunardi M et al (2022) Coronary physiology in the catheterisation laboratory\u202f: an A to Z practical guide. AsiaIntervention. https:\/\/doi.org\/10.4244\/AIJ-D-22-00022","journal-title":"AsiaIntervention"},{"key":"2351_CR7","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1016\/S0140-6736(08)60415-8","volume":"371","author":"JA Ormiston","year":"2008","unstructured":"Ormiston JA, Serruys PW, Regar E et al (2008) A bioabsorbable everolimus-eluting coronary stent system for patients with single de-novo coronary artery lesions (ABSORB): a prospective open-label trial. Lancet 371:899\u2013907. https:\/\/doi.org\/10.1016\/S0140-6736(08)60415-8","journal-title":"Lancet"},{"key":"2351_CR8","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1016\/S0140-6736(09)60325-1","volume":"373","author":"PW Serruys","year":"2009","unstructured":"Serruys PW, Ormiston JA, Onuma Y et al (2009) A bioabsorbable everolimus-eluting coronary stent system (ABSORB): 2-year outcomes and results from multiple imaging methods. Lancet 373:897\u2013910. https:\/\/doi.org\/10.1016\/S0140-6736(09)60325-1","journal-title":"Lancet"},{"key":"2351_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/J.AMJMED.2013.05.025","author":"F Ribichini","year":"2013","unstructured":"Ribichini F, Pighi M, Faggian G, Vassanelli C (2013) Bioresorbable vascular scaffolds in cardiac allograft vasculopathy: a new therapeutic option. Am J Med. https:\/\/doi.org\/10.1016\/J.AMJMED.2013.05.025","journal-title":"Am J Med"},{"key":"2351_CR10","doi-asserted-by":"publisher","first-page":"1270","DOI":"10.1016\/J.JCIN.2017.03.040","volume":"10","author":"F Ribichini","year":"2017","unstructured":"Ribichini F, Scarsini R, Zanetti C, Pesarini G (2017) First observation of a \u201cgolden tube\u201d after complete resorption of a bioresorbable vascular scaffold in a transplanted patient with cardiac allograft vasculopathy. JACC Cardiovasc Interv 10:1270\u20131272. https:\/\/doi.org\/10.1016\/J.JCIN.2017.03.040","journal-title":"JACC Cardiovasc Interv"},{"key":"2351_CR11","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1007\/s12265-015-9665-x","volume":"9","author":"M Pighi","year":"2016","unstructured":"Pighi M, Tomai F, Petrolini A et al (2016) Everolimus-eluting bioresorbable vascular scaffold system in the treatment of cardiac allograft vasculopathy: the CART (Cardiac Allograft Reparative Therapy) prospective multicenter pilot study. J Cardiovasc Transl Res 9:40\u201348. https:\/\/doi.org\/10.1007\/s12265-015-9665-x","journal-title":"J Cardiovasc Transl Res"},{"key":"2351_CR12","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1016\/j.healun.2010.05.034","volume":"29","author":"MR Costanzo","year":"2010","unstructured":"Costanzo MR, Dipchand A, Starling R et al (2010) The International Society of Heart and Lung Transplantation Guidelines for the care of heart transplant recipients. J Hear Lung Transpl 29:914\u2013956. https:\/\/doi.org\/10.1016\/j.healun.2010.05.034","journal-title":"J Hear Lung Transpl"},{"key":"2351_CR13","doi-asserted-by":"publisher","first-page":"962","DOI":"10.1002\/ccd.22975","volume":"77","author":"TW Dasari","year":"2011","unstructured":"Dasari TW, Hennebry TA, Hanna EB, Saucedo JF (2011) Drug eluting versus bare metal stents in cardiac allograft vasculopathy. Catheter Cardiovasc Interv 77:962\u2013969. https:\/\/doi.org\/10.1002\/ccd.22975","journal-title":"Catheter Cardiovasc Interv"},{"key":"2351_CR14","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1016\/j.healun.2010.05.034","volume":"29","author":"MR Costanzo","year":"2010","unstructured":"Costanzo MR, Dipchand A, Starling R et al (2010) The international society of heart and lung transplantation guidelines for the care of heart transplant recipients. J Hear Lung Transplant 29:914\u2013956. https:\/\/doi.org\/10.1016\/j.healun.2010.05.034","journal-title":"J Hear Lung Transplant"},{"key":"2351_CR15","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1093\/eurheartj\/ehq458","volume":"32","author":"J Gomez-Lara","year":"2011","unstructured":"Gomez-Lara J, Brugaletta S, Diletti R et al (2011) A comparative assessment by optical coherence tomography of the performance of the first and second generation of the everolimus-eluting bioresorbable vascular scaffolds. Eur Heart J 32:294\u2013304. https:\/\/doi.org\/10.1093\/eurheartj\/ehq458","journal-title":"Eur Heart J"},{"key":"2351_CR16","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.jacc.2023.05.003","volume":"82","author":"GW Stone","year":"2023","unstructured":"Stone GW, Kereiakes DJ, Gori T et al (2023) 5-year outcomes after bioresorbable coronary scaffolds implanted with improved technique. J Am Coll Cardiol 82:183\u2013195. https:\/\/doi.org\/10.1016\/j.jacc.2023.05.003","journal-title":"J Am Coll Cardiol"},{"key":"2351_CR17","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcard.2023.131341","author":"S Fezzi","year":"2023","unstructured":"Fezzi S, Pighi M, Del Sole PA et al (2023) Long-term intracoronary imaging and physiological measurements of bioresorbable scaffolds and untreated atherosclerotic plaques. Int J Cardiol. https:\/\/doi.org\/10.1016\/j.ijcard.2023.131341","journal-title":"Int J Cardiol"},{"key":"2351_CR18","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1016\/J.HEALUN.2005.09.016","volume":"25","author":"FM Bader","year":"2006","unstructured":"Bader FM, Kfoury AG, Gilbert EM et al (2006) Percutaneous coronary interventions with stents in cardiac transplant recipients. J Hear Lung Transplant 25:298\u2013301. https:\/\/doi.org\/10.1016\/J.HEALUN.2005.09.016","journal-title":"J Hear Lung Transplant"},{"key":"2351_CR19","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1016\/j.jcin.2010.02.005","volume":"3","author":"MS Lee","year":"2010","unstructured":"Lee MS, Tarantini G, Xhaxho J et al (2010) Sirolimus- versus paclitaxel-eluting stents for the treatment of cardiac allograft vasculopathy. JACC Cardiovasc Interv 3:378\u2013382. https:\/\/doi.org\/10.1016\/j.jcin.2010.02.005","journal-title":"JACC Cardiovasc Interv"},{"key":"2351_CR20","doi-asserted-by":"publisher","first-page":"1222","DOI":"10.1016\/j.healun.2008.08.005","volume":"27","author":"PR Reddy","year":"2008","unstructured":"Reddy PR, Gulati A, Steen L et al (2008) Outcomes of bare metal versus drug-eluting stents in allograft vasculopathy. J Hear Lung Transpl 27:1222\u20131230. https:\/\/doi.org\/10.1016\/j.healun.2008.08.005","journal-title":"J Hear Lung Transpl"},{"key":"2351_CR21","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1002\/ccd.26830","volume":"90","author":"R Cheng","year":"2017","unstructured":"Cheng R, Vanichsarn C, Patel JK et al (2017) Long-term clinical and angiographic outcomes of percutanenous coronary intervention with everolimus-eluting stents for the treatment of cardiac allograft vasculopathy. Catheter Cardiovasc Interv 90:48\u201355. https:\/\/doi.org\/10.1002\/ccd.26830","journal-title":"Catheter Cardiovasc Interv"},{"key":"2351_CR22","doi-asserted-by":"publisher","first-page":"1882","DOI":"10.1016\/j.jacc.2018.02.051","volume":"71","author":"N Moriyama","year":"2018","unstructured":"Moriyama N, Shishido K, Tanaka Y et al (2018) Neoatherosclerosis 5 years after bioresorbable vascular scaffold implantation. J Am Coll Cardiol 71:1882\u20131893. https:\/\/doi.org\/10.1016\/j.jacc.2018.02.051","journal-title":"J Am Coll Cardiol"},{"key":"2351_CR23","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/J.HEALUN.2016.06.004","volume":"36","author":"KH Park","year":"2017","unstructured":"Park KH, Sun T, Liu Z et al (2017) Relationship between markers of plaque vulnerability in optical coherence tomography and atherosclerotic progression in adult patients with heart transplantation. J Hear Lung Transplant 36:185\u2013192. https:\/\/doi.org\/10.1016\/J.HEALUN.2016.06.004","journal-title":"J Hear Lung Transplant"},{"key":"2351_CR24","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1002\/ccd.25054","volume":"83","author":"F Tomai","year":"2014","unstructured":"Tomai F, Adorisio R, De Luca L et al (2014) Coronary plaque composition assessed by intravascular ultrasound virtual histology: association with long-term clinical outcomes after heart transplantation in young adult recipients. Catheter Cardiovasc Interv 83:70\u201377. https:\/\/doi.org\/10.1002\/ccd.25054","journal-title":"Catheter Cardiovasc Interv"},{"key":"2351_CR25","doi-asserted-by":"publisher","first-page":"2289","DOI":"10.1016\/j.jacc.2020.09.547","volume":"76","author":"GW Stone","year":"2020","unstructured":"Stone GW, Maehara A, Ali ZA et al (2020) Percutaneous coronary intervention for vulnerable coronary atherosclerotic plaque. J Am Coll Cardiol 76:2289\u20132301. https:\/\/doi.org\/10.1016\/j.jacc.2020.09.547","journal-title":"J Am Coll Cardiol"},{"key":"2351_CR26","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1016\/S0140-6736(21)00249-X","volume":"397","author":"D Erlinge","year":"2021","unstructured":"Erlinge D, Maehara A, Ben-Yehuda O et al (2021) Identification of vulnerable plaques and patients by intracoronary near-infrared spectroscopy and ultrasound (PROSPECT II): a prospective natural history study. Lancet 397:985\u2013995. https:\/\/doi.org\/10.1016\/S0140-6736(21)00249-X","journal-title":"Lancet"},{"key":"2351_CR27","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.jcin.2019.09.033","volume":"13","author":"SJ Hong","year":"2020","unstructured":"Hong SJ, Mintz GS, Ahn CM et al (2020) Effect of intravascular ultrasound-guided drug-eluting stent implantation: 5-year follow-up of the IVUS-XPL randomized trial. JACC Cardiovasc Interv 13:62\u201371. https:\/\/doi.org\/10.1016\/j.jcin.2019.09.033","journal-title":"JACC Cardiovasc Interv"},{"key":"2351_CR28","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcin.2020.10.001","author":"X-F Gao","year":"2020","unstructured":"Gao X-F, Ge Z, Kong X-Q et al (2020) Three-year outcomes of the ULTIMATE trial comparing intravascular ultrasound versus angiography-guided drug-eluting stent implantation. JACC Cardiovasc Interv. https:\/\/doi.org\/10.1016\/j.jcin.2020.10.001","journal-title":"JACC Cardiovasc Interv"},{"key":"2351_CR29","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1016\/j.jcin.2016.01.030","volume":"9","author":"S Nakatani","year":"2016","unstructured":"Nakatani S, Ishibashi Y, Sotomi Y et al (2016) Bioresorption and vessel wall integration of a fully bioresorbable polymeric everolimus-eluting scaffold: optical coherence tomography, intravascular ultrasound, and histological study in a porcine model with 4-year follow-up. JACC Cardiovasc Interv 9:838\u2013851. https:\/\/doi.org\/10.1016\/j.jcin.2016.01.030","journal-title":"JACC Cardiovasc Interv"}],"container-title":["Clinical Research in Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00392-023-02351-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00392-023-02351-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00392-023-02351-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,2]],"date-time":"2024-07-02T08:10:39Z","timestamp":1719907839000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00392-023-02351-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,3]]},"references-count":29,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2024,7]]}},"alternative-id":["2351"],"URL":"https:\/\/doi.org\/10.1007\/s00392-023-02351-9","relation":{},"ISSN":["1861-0684","1861-0692"],"issn-type":[{"value":"1861-0684","type":"print"},{"value":"1861-0692","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1,3]]},"assertion":[{"value":"31 August 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 November 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 January 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"JD received institutional grant\/research support from Astra Zeneca, Abbott Vascular, Boston Scientific, ACIST Medical, Medtronic, Microport, Pie Medical, and ReCor medical. All the other authors report no relevant conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}